N. S. Bin Sabbar, “Addition of rituximab to hyper-CVAD improves overall survival in newly diagnosed Burkitt leukemia/lymphoma from the Middle East and North Africa region”, Int J Community Med Public Health, vol. 6, no. 10, pp. 4199–4203, Sep. 2019.